id: NEW:dialysis_treatment_to_hepatitis_c_prevalence
name: Hemodialysis Treatment â†’ Hepatitis C Virus Infection
from_node:
  node_id: NEW:dialysis_treatment
  node_name: Hemodialysis Treatment
to_node:
  node_id: hepatitis_c_prevalence
  node_name: Hepatitis C Virus Infection
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Patients with chronic kidney disease require regular hemodialysis treatment,
  typically 3 times per week in dialysis centers'
- 'Step 2: In-center hemodialysis involves repeated vascular access, blood exposure,
  and shared equipment/environment among multiple patients'
- 'Step 3: Nosocomial transmission of HCV occurs within hemodialysis units through
  breaches in infection control practices, contaminated equipment, or environmental
  surfaces'
- 'Step 4: Patients on long-term hemodialysis accumulate exposure risk over time,
  with higher HCV prevalence (~10% in DOPPS studies) compared to general population
  (~1%)'
- 'Step 5: Transfers between dialysis facilities and modalities create additional
  opportunities for HCV exposure and transmission'
evidence:
  quality_rating: A
  n_studies: 125
  primary_citation: 'C. Gordon et al. 2019. Prevention, Diagnosis, Evaluation, and
    Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of
    the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
    Annals of Internal Medicine.'
  supporting_citations: []
description: Hemodialysis treatment is associated with elevated hepatitis C virus
  infection prevalence through nosocomial transmission mechanisms in dialysis settings.
  The KDIGO 2018 guideline, based on systematic review of 125 studies, documents approximately
  10% HCV seroprevalence among hemodialysis patients compared to 1% in the general
  US population. This elevated risk results from repeated vascular access, blood exposure,
  shared equipment, and environmental contamination in dialysis centers. The guideline
  recommends universal HCV screening at dialysis initiation and upon facility transfers
  to identify infected patients and prevent further transmission.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 10.0
    type: prevalence_ratio
    ci_lower: null
    ci_upper: null
  p_value: null
  sample_size: null
moderators:
- name: Duration of hemodialysis treatment
  direction: strengthens
  strength: strong
  description: Long-term hemodialysis increases cumulative exposure risk for HCV transmission
- name: Infection control practices
  direction: weakens
  strength: strong
  description: Strict adherence to infection control protocols in dialysis units reduces
    nosocomial HCV transmission
- name: Dialysis modality
  direction: weakens
  strength: moderate
  description: Home hemodialysis and peritoneal dialysis have lower transmission risk
    than in-center hemodialysis due to reduced shared equipment exposure
- name: Facility transfers
  direction: strengthens
  strength: moderate
  description: Transfers between dialysis facilities or modalities increase exposure
    to potentially varied infection control standards
